HomeORY • BME
add
Oryzon Genomics SA
Previous close
€3.26
Day range
€3.17 - €3.30
Year range
€1.40 - €4.02
Market cap
252.10M EUR
Avg Volume
874.31K
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Times Colonist
7 hours ago
Basic materials stocks weigh on S&P/TSX composite, U.S. markets move higher
0.17%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.09M | 82.14% |
Net income | 395.00K | 128.64% |
Net profit margin | — | — |
Earnings per share | 0.01 | 146.65% |
EBITDA | -5.05M | -83.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 75.20M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 395.00K | 128.64% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2000
Website
Employees
47
